Showing results (1-10 of 44) with videos related to
Sort By:
Pageof 5
Pharmacological Reports : PR|August 17, 2013
BDNF and VEGF in the pathogenesis of stress-induced affective diseases: an insight from experimental studiesMarta Nowacka, Ewa ObuchowiczNaunyn-Schmiedeberg'S Archives of Pharmacology|January 27, 2024
How depression and antidepressant drugs affect endocannabinoid system?-review of clinical and preclinical studiesJonasz Dragon, Ewa ObuchowiczNeuropeptides|March 3, 2019
Are neuropeptides relevant for the mechanism of action of SSRIs?Miłosz Gołyszny, Ewa ObuchowiczPharmacological Reports : PR|February 13, 2009
Antiapoptotic action of lithium and valproateAnna M Bielecka, Ewa ObuchowiczNeuropeptides|July 2, 2011
Vascular endothelial growth factor (VEGF) and its role in the central nervous system: a new element in the neurotrophic hypothesis of antidepressant drug actionMarta Maria Nowacka, Ewa ObuchowiczAlternative Therapies in Health and Medicine|January 15, 2018
Medicinal Plant Materials in the Treatment of Anxiety Disorders: Neurobiological AspectsMiłosz Jan Gołyszny, Ewa ObuchowiczExperimental Biology and Medicine (Maywood, N.J.)|August 24, 2013
Antidepressant drugs as a complementary therapeutic strategy in cancerAnna M Bielecka, Ewa ObuchowiczPharmacological Reports : PR|December 31, 2005
Lack of effect of some dopamine and non-dopamine receptor ligands on amphetamine-induced changes in the rat brain neuropeptide Y systemEwa Obuchowicz, Zbigniew S HermanNeuropeptides|October 16, 2025
Role of interplay between endocannabinoids and neuropeptides in pathogenesis and therapy of depressive and anxiety disordersMiłosz Gołyszny, Jonasz Dragon, Ewa ObuchowiczPharmacology, Biochemistry, and Behavior|March 16, 2025
Co-treatment with cannabidiol and escitalopram in ineffective doses induces antidepressant effect in maternally separated male adolescent ratsJonasz Dragon, Miłosz Gołyszny, Ewa ObuchowiczPageof 5